drugset / Trial / NCT05320172

Platelet Rich Plasma in Corneal Surface Diseases

NCT05320172

Phase 3 Unknown 70 enrolled Assiut University
NaSingle-groupOpen-labelTreatment

Summary

The Aim of the study is to evaluate the efficacy of platelet rich plasma eye drops in the management of different corneal surface disorders. PRP is a blood sample with a concentrated platelet count, and numerous growth factors that are associated with conjunctival and corneal wound healing process. which is an important advantage over other products. PRP eye drops recently are proving to be an effective and potent therapeutic approach to promote corneal wound re-epithelization and promote ocular surface regeneration in different pathological conditions.

Timeline

Start
2023-06
Primary completion
2024-06
Completion
2024-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Topical

Indications